GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Traditional Chinese Medicine Holdings Co Ltd (HKSE:00570) » Definitions » Return-on-Tangible-Equity

China Traditional Chinese Medicine Holdings Co (HKSE:00570) Return-on-Tangible-Equity : 11.98% (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is China Traditional Chinese Medicine Holdings Co Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. China Traditional Chinese Medicine Holdings Co's annualized net income for the quarter that ended in Dec. 2023 was HK$1,545 Mil. China Traditional Chinese Medicine Holdings Co's average shareholder tangible equity for the quarter that ended in Dec. 2023 was HK$12,904 Mil. Therefore, China Traditional Chinese Medicine Holdings Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was 11.98%.

The historical rank and industry rank for China Traditional Chinese Medicine Holdings Co's Return-on-Tangible-Equity or its related term are showing as below:

HKSE:00570' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.02   Med: 31.77   Max: 75.55
Current: 11.12

During the past 13 years, China Traditional Chinese Medicine Holdings Co's highest Return-on-Tangible-Equity was 75.55%. The lowest was 7.02%. And the median was 31.77%.

HKSE:00570's Return-on-Tangible-Equity is ranked better than
63.72% of 940 companies
in the Drug Manufacturers industry
Industry Median: 6.475 vs HKSE:00570: 11.12

China Traditional Chinese Medicine Holdings Co Return-on-Tangible-Equity Historical Data

The historical data trend for China Traditional Chinese Medicine Holdings Co's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Traditional Chinese Medicine Holdings Co Return-on-Tangible-Equity Chart

China Traditional Chinese Medicine Holdings Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.23 23.10 21.61 7.02 11.04

China Traditional Chinese Medicine Holdings Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.06 8.00 6.50 10.31 11.98

Competitive Comparison of China Traditional Chinese Medicine Holdings Co's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, China Traditional Chinese Medicine Holdings Co's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Traditional Chinese Medicine Holdings Co's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Traditional Chinese Medicine Holdings Co's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where China Traditional Chinese Medicine Holdings Co's Return-on-Tangible-Equity falls into.



China Traditional Chinese Medicine Holdings Co Return-on-Tangible-Equity Calculation

China Traditional Chinese Medicine Holdings Co's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=1405.725/( (12102.038+13361.458 )/ 2 )
=1405.725/12731.748
=11.04 %

China Traditional Chinese Medicine Holdings Co's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=1545.418/( (12445.943+13361.458)/ 2 )
=1545.418/12903.7005
=11.98 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


China Traditional Chinese Medicine Holdings Co  (HKSE:00570) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


China Traditional Chinese Medicine Holdings Co Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of China Traditional Chinese Medicine Holdings Co's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


China Traditional Chinese Medicine Holdings Co (HKSE:00570) Business Description

Traded in Other Exchanges
Address
288 Hennessy Road, Room 1601, Emperor Group Centre, Wanchai, Hong Kong, HKG
China Traditional Chinese Medicine Holdings Co Ltd is engaged in the Chinese healthcare sector. The company functions through five segments, finished drugs; concentrated TCM granules; TCM decoction pieces; TCM healthcare complex, and Local TCM integrated operation. It generates maximum revenue from the concentrated TCM granules segment. Geographically, it derives a majority of its revenue from Mainland China.

China Traditional Chinese Medicine Holdings Co (HKSE:00570) Headlines

No Headlines